Nanomaterial Delivery Systems for mRNA Vaccines

Nanomaterial Delivery Systems for mRNA Vaccines

The recent success of mRNA vaccines in SARS-CoV-2 clinical trials is in part due to the development of lipid nanoparticle delivery systems that not only efficiently express the mRNA-encoded immunogen after intramuscular injection, but also play roles as adjuvants and in vaccine reactogenicity. We pr...

Full description

Bibliographic Details
Main Authors: Michael D. Buschmann, Manuel J. Carrasco, Suman Alishetty, Mikell Paige, Mohamad Gabriel Alameh, Drew Weissman
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Vaccines
Subjects:
mRNA
lipid nanoparticle
ionizable lipid
vaccine
SARS-CoV-2
Online Access:https://www.mdpi.com/2076-393X/9/1/65

Internet

https://www.mdpi.com/2076-393X/9/1/65

Similar Items